[Pneumonia after cytostatic drug therapy]
Related Experiment Video
Updated: Oct 13, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Abstract:
On account of its high mortality, pneumonia is a particularly feared infectious complication in granulocytopenic patients. One of the main reasons for the fatal outcome is the increasing rate of pulmonary mycoses. Fungal infections offer considerable problems concerning diagnostics and therapy. To improve the prognosis of pulmonary mycoses undelayed diagnostics--even by more invasive methods like bronchoalveolar lavage--and immediate start of antifungal treatment (Amphotericin B/5-Flucytosine are still considered as standard therapy) is necessary. A further problem are gram positive organisms, insufficiently prevented by the standard prophylactic regimens. Particularly pneumonia by Staphylococcus aureus and Viridans-Streptococci may show lethal outcome. The initial treatment with glycopeptides is discussed. Treatment of infections by gram negative organisms however, is less controversial. Finally pneumonias in granulocytopenic patients present serious problems in diagnostics and therapy requiring interdisciplinary co-operation of hematology, radiology, pneumology and microbiology.
Insights
Pneumonia in granulocytopenic patients is a serious threat, often caused by fungal infections and gram-positive bacteria. Early diagnosis and prompt treatment are crucial for improving outcomes in these high-risk individuals.
Area of Science:
- Infectious Diseases
- Hematology
- Pulmonology
Context:
- Granulocytopenic patients face high mortality from pneumonia, a severe infectious complication.
- Pulmonary mycoses (fungal infections) are a significant cause of fatal outcomes in this population.
- Standard prophylactic regimens inadequately prevent infections by certain gram-positive organisms.
Purpose:
- To highlight the diagnostic and therapeutic challenges of pneumonia in granulocytopenic patients.
- To emphasize the need for early and accurate diagnosis, including invasive methods like bronchoalveolar lavage.
- To discuss current and potential treatment strategies for various causative agents.
Summary:
- Pneumonia in granulocytopenic patients presents complex diagnostic and therapeutic issues, particularly due to pulmonary mycoses and gram-positive bacterial infections like Staphylococcus aureus and Viridans-Streptococci.
- Prompt diagnosis, potentially via bronchoalveolar lavage, followed by immediate antifungal treatment (Amphotericin B/5-Flucytosine) is essential for improving prognosis.
- Initial treatment with glycopeptides for gram-positive infections is considered, while gram-negative infections have more established therapeutic approaches.
Impact:
- Improved patient outcomes through timely and appropriate interventions for pneumonia in immunocompromised individuals.
- Highlights the critical need for interdisciplinary collaboration among hematology, radiology, pneumology, and microbiology.
- Underscores the importance of advancing diagnostic and therapeutic strategies for life-threatening infections in granulocytopenic patients.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumothorax-II
Clinical Manifestations:
Atypical Pneumonia
Pneumonia I: Introduction

